Moneycontrol PRO
Exclusive Cash Offers up to ₹50 lakhs
Outskill Gea AI
HomeNewsBusinessStocksBuy Ajanta Pharma; target of Rs 3220: ICICIdirect

Buy Ajanta Pharma; target of Rs 3220: ICICIdirect

ICICIdirect.com is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 3220, in its research report dated January 30, 2015.

February 05, 2015 / 13:44 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More
    ICICIdirect.com's report on Ajanta Pharma

    Revenues grew 21.8% YoY to Rs 362.6 crore, in line with I-direct estimate of Rs 356.5 crore on the back of 15% growth in exports and 35% growth in domestic sales

    EBITDA margins improved 393 bps YoY to 36.2%, higher than I-direct estimate of 31.6%. EBITDA increased 35.2% YoY to Rs 131.4 crore against I-direct estimate of Rs 112.6 crore

    Net profit increased 35.7% YoY to Rs 84.7 crore, higher than I-direct estimate of Rs 79.0 crore, driven by a strong operational performance "The Q3 numbers have once again demonstrated Ajanta’s consistency in delivering above average numbers both in India and abroad. In domestic formulations, APL continues to register robust growth. In the exports space both the Philippines and Franco-African markets continue to thrive on the back of consistent product launches and base business growth. On the margins front, the company has consistently been improving its margin on the back of an improved product mix. We expect revenues, EBITDA and net profit to grow at a CAGR of 22%, 23% and 25%, respectively. We have ascribed a target price of Rs 3220 based on 25x (1x of PEG) based on FY17E EPS of Rs 129. Buy the stock", says ICICIdirect.com research report.

    For all recommendations, click here  

    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
    first published: Feb 5, 2015 01:44 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseGen AI Masterclass